Deerfield Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,600,000
Closed -$16.4M – 112
2023
Q2
$16.4M Hold
1,600,000
– – 0.35% 54
2023
Q1
$16.2M Hold
1,600,000
– – 0.36% 59
2022
Q4
$16M Hold
1,600,000
– – 0.33% 65
2022
Q3
$15.6M Hold
1,600,000
– – 0.31% 70
2022
Q2
$15.5M Hold
1,600,000
– – 0.32% 69
2022
Q1
$15.5M Hold
1,600,000
– – 0.35% 57
2021
Q4
$15.7M Hold
1,600,000
– – 0.33% 68
2021
Q3
$15.7M Buy
+1,600,000
New +$15.8M 0.31% 79

Deerfield Management's DALS Position: Q3 2023 in Review

Deerfield Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 1,600,000 shares — an estimated $16.4M sold.

Deerfield Management first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $16.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Deerfield Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Deerfield Management sold 1,600,000 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $16.4M.
  • Deerfield Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 8 quarters.
  • Deerfield Management's DA32 Life Science Tech Acquisition Corp position peaked at $16.4M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Deerfield Management's 13F filing for Q3 2023, filed 14 Nov 2023.